Published in Blood Weekly, September 30th, 1996
This significant increase of blood perfusion might contribute toward its efficacy as a resuscitative agent, indicated Ashok Kumar, University of Illinois at Chicago, Chicago, Illinois, and colleagues at the VI International Symposium on Blood Substitutes, held August 5-7, 1996, at McGill University, in Montreal, Quebec, Canada.
The researchers said the purpose of the study was to determine the effect of diaspirin crosslinked hemoglobin (DCLHb; a hemoglobin-based blood substitute developed by Baxter Healthcare Corporation) on microvascular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Blood Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.